×

Novartis, GSK deal 'win win': Pro

3:00 AM ET Tue, 22 April 2014

Christian Gattiker-Ericsson, chief strategist and head of research at Julius Bär, says the multibillion-dollar deal between GSK and Novartis is "win win" for both companies.